Pfizer’s Torcetrapib/Lipitor Raises HDL Cholesterol, But Blood Pressure Too

Apparent increases in systolic blood pressure caused by Pfizer's torcetrapib/Lipitor (atorvastatin) combination will be investigated in further clinical studies, the firm said

More from Archive

More from Pink Sheet